News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Romualdo Barroso: Sara Tolaney will present the primary results of DESTINY-Breast09 at ASCO 2025
Romualdo Barroso and Sara Tolaney
May 3, 2025, 04:38

Romualdo Barroso: Sara Tolaney will present the primary results of DESTINY-Breast09 at ASCO 2025

Romualdo Barroso, Medical Oncologist and National Leader of Breast Oncology at Rede Americas, shared a post on X:

“Now is oficial
Dr. Sara Tolaney will present the primary results of DB09 on June 2nd at Hall D1 at 7:30am.”

Sara Tolaney

ASCO 2025 cancer OncoDaily Oncology Romualdo Barroso Sara Tolaney
Special Coverage
Blog
May 3, 2025, 04:38
Romualdo Barroso: Sara Tolaney will present the primary results of DESTINY-Breast09 at ASCO 2025
Opinion
May 3, 2025, 04:33
ESOPEC trial updates from ESTRO 2025: Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer
Blog
May 3, 2025, 04:24
Icro Meattini: Regional Nodal Irradiation in Node-Negative PST Cases - Teaching Lecture at ESTRO25
Blog
May 3, 2025, 04:19
EGFR Positive Lung Cancer UK got 2nd places in London Marathon 2026 Run
Blog
May 3, 2025, 04:17
Ane Appelt: Follow our dedicated Reirradiation Journey at ESTRO25
Dialogues
May 3, 2025, 04:09
Clinician insights on the opportunities and challenges in ovarian cancer in LMIC - World Ovarian Cancer Coalition
Opinion
May 3, 2025, 02:52
TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Blog
May 3, 2025, 02:06
Celebrating Excellence: Lifetime Achievement Awards at ESTRO 2025
Blog
May 2, 2025, 21:11
This Is Research in Action: But It’s Not Enough - The Breast Cancer Research Foundation
Blog
May 2, 2025, 21:01
Debra Patt: Planning a Better Future for the Patients We Serve at the Community Oncology Alliance 2025
Blog
May 2, 2025, 20:50
Herbert Loong: Presenting our data on D3S-001 at AACR 2025
Blog
May 2, 2025, 20:38
Chandler Park: Discussing FDA-Approved Chemoimmunotherapy for Bladder Cancer with Muhamed Baljevic